{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:23:32Z","timestamp":1781702612913,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005809","name":"Hyderabad Eye Research Foundation","doi-asserted-by":"publisher","award":["(LEC-01-19-215)"],"award-info":[{"award-number":["(LEC-01-19-215)"]}],"id":[{"id":"10.13039\/501100005809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00417-024-06391-3","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T09:02:07Z","timestamp":1707210127000},"page":"2163-2169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Antibiotic susceptibility in Endophthalmitis Management Study and intravitreal antibiotic practice trend in India\u2014EMS Report #5"],"prefix":"10.1007","volume":"262","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1295-4528","authenticated-orcid":false,"given":"Taraprasad","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6807-2121","authenticated-orcid":false,"given":"Suchita","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8421-1977","authenticated-orcid":false,"given":"Joveeta","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3590-7759","authenticated-orcid":false,"given":"Jay","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4465-4765","authenticated-orcid":false,"given":"Akash","family":"Belenje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6812-1894","authenticated-orcid":false,"given":"Umesh C.","family":"Behera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudvij","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2589-666X","authenticated-orcid":false,"given":"Vivek Pravin","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,6]]},"reference":[{"key":"6391_CR1","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.4103\/ijo.IJO_199_21","volume":"69","author":"T Das","year":"2021","unstructured":"Das T, Dave VP, Dogra A, Joseph J, Sharma (2021) Endophthalmitis management study. Report #1 Protocol. Indian J Ophthalmol 69:1936\u20131941","journal-title":"Indian J Ophthalmol"},{"key":"6391_CR2","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1001\/archopht.1995.01100120009001","volume":"113","author":"Endophthalmitis Vitrectomy Study Group","year":"1995","unstructured":"Endophthalmitis Vitrectomy Study Group (1995) Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 113:1479\u20131496","journal-title":"Arch Ophthalmol"},{"key":"6391_CR3","doi-asserted-by":"publisher","first-page":"e651","DOI":"10.1111\/aos.13623","volume":"96","author":"A Grzybowski","year":"2018","unstructured":"Grzybowski A, Turczynowska M, Kuhn F (2018) The treatment of postoperative endophthalmitis: should we still follow the endophthalmitis vitrectomy study more than two decades after its publication? Acta Ophthalmol 96:e651\u2013e654","journal-title":"Acta Ophthalmol"},{"key":"6391_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s40123-020-00270-w","volume":"9","author":"A Grzybowski","year":"2020","unstructured":"Grzybowski A, Turczynowska M, Schwartz SG et al (2020) The role of systemic antimicrobials in the treatment of endophthalmitis: a review and an international perspective. Ophthalmol Ther 9:485\u2013498","journal-title":"Ophthalmol Ther"},{"key":"6391_CR5","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00417-005-0082-8","volume":"243","author":"F Kuhn","year":"2005","unstructured":"Kuhn F, Gini G (2005) Ten years after... are findings of the Endophthalmitis Vitrectomy Study still relevant today? Graefe\u2019s Arch Clin Exp Ophthalmol 243:1197\u20131199","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"6391_CR6","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.ophtha.2006.01.009","volume":"113","author":"F Kuhn","year":"2006","unstructured":"Kuhn F, Gini G (2006) Vitrectomy for endophthalmitis. Ophthalmology 113:714","journal-title":"Ophthalmology"},{"key":"6391_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/ceo.12833","volume":"45","author":"VP Dave","year":"2017","unstructured":"Dave VP, Pathengay A, Nishant K et al (2017) Clinical presentations, risk factors, and outcome of ceftazidime- resistant gram-negative endophthalmitis. Clin Exp Ophthalmol 45:254\u2013260","journal-title":"Clin Exp Ophthalmol"},{"key":"6391_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1869-5760-3-62","volume":"3","author":"A Jindal","year":"2013","unstructured":"Jindal A, Pathengay A, Khera M et al (2013) Combined ceftazidime and amikacin resistance among gram-negative isolates in acute-onset postoperative endophthalmitis: prevalence, antimicrobial susceptibilities, and visual acuity outcome. J Ophthal Inflam Inf 3:62. https:\/\/doi.org\/10.1186\/1869-5760-3-62","journal-title":"J Ophthal Inflam Inf"},{"key":"6391_CR9","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/s41433-019-0380-8","volume":"33","author":"J Joseph","year":"2019","unstructured":"Joseph J, Sontam B, Guda SJM et al (2019) Trends in microbiological spectrum of endophthalmitis at a single tertiary care ophthalmic hospital in India: a review of 25 years. Eye (Lond, Engl) 33:1090\u20131095","journal-title":"Eye (Lond, Engl)"},{"key":"6391_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ajoc.2018.02.030","volume":"10","author":"HS Shivaramaiah","year":"2018","unstructured":"Shivaramaiah HS, Relhan N, Pathengay A et al (2018) Endophthalmitis caused by gram-positive bacteria resistant to vancomycin: clinical settings, causative organisms, antimicrobial susceptibilities, and treatment outcomes. Am J Ophthalmol Case Rep 10:211\u2013214","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"1","key":"6391_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1869-5760-3-46","volume":"3","author":"M Khera","year":"2013","unstructured":"Khera M, Pathengay A, Jindal A et al (2013) Vancomycin-resistant Gram-positive bacterial endophthalmitis: epidemiology, treatment options, and outcomes. J Ophthal Inflamm Infect 3(1):46. https:\/\/doi.org\/10.1186\/1869-5760-3-46","journal-title":"J Ophthal Inflamm Infect"},{"key":"6391_CR12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0002-9394(99)00112-9","volume":"128","author":"DY Kunimoto","year":"1999","unstructured":"Kunimoto DY, Das T, Sharma S et al (1999) Microbiologic spectrum and susceptibility of isolates: part I. Postoperative endophthalmitis. Endophthalmitis Research Group. Am J Ophthalmol 128:240\u2013242","journal-title":"Am J Ophthalmol"},{"key":"6391_CR13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.4103\/ijo.IJO_509_17","volume":"65","author":"P Lalitha","year":"2017","unstructured":"Lalitha P, Sengupta S, Ravindran RD et al (2017) A literature review and update on the incidence and microbiology spectrum of post cataract surgery endophthalmitis over past 2 decades in India. Indian J Ophthalmol 65:673\u2013677","journal-title":"Indian J Ophthalmol"},{"key":"6391_CR14","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.4103\/ijo.IJO_755_17","volume":"65","author":"T Das","year":"2017","unstructured":"Das T (2017) Redefining evidence in the management of acute post-cataract surgery endophthalmitis in India - the 2014 Adenwalla Oration, All India Ophthalmological Society. Indian J Ophthalmol 65:1403\u20131406","journal-title":"Indian J Ophthalmol"},{"issue":"8","key":"6391_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/0196-4399(89)90068-8","volume":"11","author":"WJ Novick","year":"1989","unstructured":"Novick WJ (1989) Development of in vitro susceptibility testing criteria and quality control parameters. Clin Microbiol News 11(8):60\u201362","journal-title":"Clin Microbiol News"},{"key":"6391_CR16","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB et al (2012) Multidrug\u2013resistant, extensively drug\u2013resistant and pan-drug\u2013resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:3268\u20133281","journal-title":"Clin Microbiol Infect"},{"key":"6391_CR17","unstructured":"Clinical and Laboratory Standard Institute (2008) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved M38-A, 2nd edn. 2008. Wayne, CLSI, p 52. https:\/\/clsi.org\/media\/1455\/m38a2_sample.pdf"},{"key":"6391_CR18","doi-asserted-by":"publisher","first-page":"512","DOI":"10.4103\/0301-4738.86328","volume":"59","author":"L Pradhan","year":"2011","unstructured":"Pradhan L, Sharma S, Nalamada S et al (2011) Natamycin in the treatment of keratomycosis: correlation of treatment outcome and in vitro susceptibility of fungal isolates. Indian J Ophthalmol 59:512\u2013514","journal-title":"Indian J Ophthalmol"},{"key":"6391_CR19","doi-asserted-by":"publisher","unstructured":"Rubinstein E, Keynan Y (2014) Vancomycin revisited- 60 years later. Front Public Health 2. https:\/\/doi.org\/10.3389\/fpubh.2014.00217","DOI":"10.3389\/fpubh.2014.00217"},{"key":"6391_CR20","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1128\/AAC.4.4.396","volume":"4","author":"MG Bergeron","year":"1973","unstructured":"Bergeron MG, Brusch JL, Barza M, Weinstein L (1973) Bactericidal activity and pharmacology of cefazolin. Antimicrob Agents Chemother 4:396\u2013401","journal-title":"Antimicrob Agents Chemother"},{"key":"6391_CR21","doi-asserted-by":"publisher","first-page":"a027029","DOI":"10.1101\/cshperspect.a027029","volume":"6","author":"KM Krause","year":"2016","unstructured":"Krause KM, Serio AW, Kane TR, Connolly LE (2016) Aminoglycosides: an overview. Cold Spring Harb Perspect Med 6:a027029. https:\/\/doi.org\/10.1101\/cshperspect.a027029","journal-title":"Cold Spring Harb Perspect Med"},{"key":"6391_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2165\/00003495-198529020-00002","volume":"29","author":"DM Richards","year":"1985","unstructured":"Richards DM, Brogden RN (1985) Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 29:105\u2013161","journal-title":"Drugs"},{"key":"6391_CR23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/QCO.0b013e328332e672","volume":"22","author":"RL Nation","year":"2009","unstructured":"Nation RL, Li J (2009) Colistin in the 21st century. Curr Opin Infect Dis 22:535\u2013543","journal-title":"Curr Opin Infect Dis"},{"issue":"Suppl 3","key":"6391_CR24","doi-asserted-by":"publisher","first-page":"S389","DOI":"10.1093\/clinids\/7.Supplement_3.S389","volume":"7","author":"H Kropp","year":"1985","unstructured":"Kropp H, Gerckens L, Sundelof JG, Kahan FM (1985) Antibacterial activity of imipenem: the first thienamycin antibiotic. Rev Infect Dis 7(Suppl 3):S389-410","journal-title":"Rev Infect Dis"},{"key":"6391_CR25","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2165\/00003495-199957050-00017","volume":"57","author":"CM Perry","year":"1999","unstructured":"Perry CM, Markham A (1999) Piperacillin\/tazobactam: an updated review of its use in the treatment of bacterial infections. Drugs 57:805\u2013843","journal-title":"Drugs"},{"key":"6391_CR26","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1086\/523576","volume":"45","author":"V Nagappan","year":"2007","unstructured":"Nagappan V, Deresinski S, Posaconazole (2007) A broad-spectrum triazole antifungal agent. Clin Infect Dis 45:1610\u20131617","journal-title":"Clin Infect Dis"},{"key":"6391_CR27","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1128\/AAC.42.11.3018","volume":"42","author":"EK Manavathu","year":"1998","unstructured":"Manavathu EK, Cutright JL, Chandrasekar PH (1998) Organism-dependent fungicidal activities of azoles. Antimicrob Agents Chemother 42:3018\u20133021","journal-title":"Antimicrob Agents Chemother"},{"key":"6391_CR28","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/jac\/dkg117","volume":"51","author":"V Letscher-Bru","year":"2003","unstructured":"Letscher-Bru V, Herbrecht R (2003) Caspofungin: the first representative of a new antifungal class. J Antimicrob Chemother 51:513\u2013521","journal-title":"J Antimicrob Chemother"},{"key":"6391_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/17469899.2020.1820322","volume":"15","author":"T Das","year":"2020","unstructured":"Das T, Agarwal M, Behera U et al (2020) Diagnosis and management of fungal endophthalmitis: India perspective. Expert Rev Ophthalmol 15:355\u2013365","journal-title":"Expert Rev Ophthalmol"},{"key":"6391_CR30","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1086\/381972","volume":"38","author":"GA Pankey","year":"2004","unstructured":"Pankey GA, Sabath LD (2004) Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of gram-positive bacterial infections. Clin Infect Dis 38:864\u2013870","journal-title":"Clin Infect Dis"},{"key":"6391_CR31","unstructured":"Half life- StarPearls-NCBI Bookshelf. Available from: www.ncbi.nih.gov >book > NBK554498. [last accessed 28 August 2023)"},{"key":"6391_CR32","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0896-1549(05)70261-3","volume":"14","author":"T Thomas","year":"2001","unstructured":"Thomas T, Galiani D, Brod RD (2001) Gentamicin and other antibiotic toxicity. Oph Clin N Am 14:611\u2013624","journal-title":"Oph Clin N Am"},{"key":"6391_CR33","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.4103\/0301-4738.126991","volume":"62","author":"P Samant","year":"2014","unstructured":"Samant P, Ramugade S (2014) Successful use of intravitreal and systemic colistin in treating multidrug-resistant Pseudomonas aeruginosa post-operative endophthalmitis. Indian J Ophthalmol 62:1167\u20131170","journal-title":"Indian J Ophthalmol"},{"key":"6391_CR34","doi-asserted-by":"publisher","first-page":"596","DOI":"10.4103\/ijo.IJO_809_17","volume":"66","author":"M Dogra","year":"2018","unstructured":"Dogra M, Sharma M, Katoch D et al (2018) Management of multi-drug resistant endogenous Klebsiella pneumoniae endophthalmitis with intravitreal and systemic colistin. Indian J Ophthalmol 66:596\u2013597","journal-title":"Indian J Ophthalmol"},{"key":"6391_CR35","first-page":"52","volume":"4","author":"M Taneja","year":"2016","unstructured":"Taneja M, Senthil S, Paulose R et al (2016) Intravitreal colistin for multi drug resistant acute endophthalmitis following Descemet-stripping endothelial keratoplasty due to Klebsiella pneumoniae. J Cat Refrac Surg Case Rep 4:52\u201356","journal-title":"J Cat Refrac Surg Case Rep"},{"key":"6391_CR36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1080\/15569527.2021.1945617","volume":"40","author":"M Ozbek","year":"2021","unstructured":"Ozbek M, Odabasi M, Erdur SK et al (2021) Determination of the retinal toxicity of intravitreal colistin in rabbit eyes. Cutan Ocul Toxicol. 40:300\u201304","journal-title":"Cutan Ocul Toxicol."},{"key":"6391_CR37","doi-asserted-by":"publisher","first-page":"820","DOI":"10.4103\/ijo.IJO_1336_17","volume":"66","author":"PK Maharana","year":"2018","unstructured":"Maharana PK, Chhablani JK, Das TP et al (2018) All India Ophthalmological Society members survey results: cataract surgery antibiotic prophylaxis current practice pattern 2017. Indian J Ophthalmol 66:820\u2013824","journal-title":"Indian J Ophthalmol"},{"key":"6391_CR38","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.3390\/antibiotics12081246","volume":"12","author":"A Yap","year":"2023","unstructured":"Yap A, Muttaiyah S, Welch S, Niederer RL (2023) Role of antimicrobial resistance in outcomes of acute Endophthalmitis. Antibiotics (Basel) 12:1246. https:\/\/doi.org\/10.3390\/antibiotics12081246","journal-title":"Antibiotics (Basel)"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06391-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-024-06391-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06391-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T14:08:05Z","timestamp":1720015685000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-024-06391-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,6]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["6391"],"URL":"https:\/\/doi.org\/10.1007\/s00417-024-06391-3","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,6]]},"assertion":[{"value":"31 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ethics committee approved the EMS (LEC 01\u201319-215), and all patients were treated according to the tenets of the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}